Romidepsin: a novel histone deacetylase inhibitor for cancer

By Bertino Erin M   Otterson Gregory A  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1151-1158

Informa Healthcare

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-06 ,pp. : 519-527

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

By Bose Prithviraj   Simmons Gary L   Grant Steven  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 6, 2013-09 ,pp. : 723-738

Informa Healthcare

Access to resources Recommend Favorite

Effect of a Histone Deacetylase Inhibitor on Human Cardiac Mass

By Shizukuda Yukitaka   Piekarz Richard   Bates Susan   Sachdev Vandana   Finkel Toren   Rosing Douglas  

Cardiovascular Drugs and Therapy, Vol. 19, Iss. 1, 2005-01 ,pp. : 89-90

Springer Publishing Company

Access to resources Recommend Favorite

Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor

By Boumber Yanis   Younes Anas   Garcia-Manero Guillermo  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 823-829

Informa Healthcare

Access to resources Recommend Favorite